|
Cosman, F; Baz-Hecht, M; Cushman, M et al. (2005) Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature. Thromb Res 116:1-13
|
|
Cosman, F; Nieves, J; Woelfert, L et al. (2001) Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal. J Bone Miner Res 16:925-31
|
|
Cosman, F; Shen, V; Morgan, D et al. (2000) Biochemical responses of bone metabolism to 1,25-dihydroxyvitamin D administration in black and white women. Osteoporos Int 11:271-7
|
|
Cosman, F; Nieves, J; Morgan, D et al. (1999) Parathyroid hormone secretory response to EDTA-induced hypocalcemia in black and white premenopausal women. Calcif Tissue Int 65:257-61
|
|
Cosman, F; Lindsay, R (1999) Selective estrogen receptor modulators: clinical spectrum. Endocr Rev 20:418-34
|
|
Cosman, F; Nieves, J; Woelfert, L et al. (1998) Parathyroid responsivity in postmenopausal women with osteoporosis during treatment with parathyroid hormone. J Clin Endocrinol Metab 83:788-90
|
|
Formica, C A; Nieves, J W; Cosman, F et al. (1998) Comparative assessment of bone mineral measurements using dual X-ray absorptiometry and peripheral quantitative computed tomography. Osteoporos Int 8:460-7
|
|
Cosman, F; Lindsay, R (1998) Is parathyroid hormone a therapeutic option for osteoporosis? A review of the clinical evidence. Calcif Tissue Int 62:475-80
|
|
Cosman, F; Nieves, J; Woelfert, L et al. (1998) Alendronate does not block the anabolic effect of PTH in postmenopausal osteoporotic women. J Bone Miner Res 13:1051-5
|
|
Cosman, F; Nieves, J; Komar, L et al. (1998) Fracture history and bone loss in patients with MS. Neurology 51:1161-5
|
Showing the most recent 10 out of 20 publications
